| CAPRICOR THERAPEUTICS |
| USA |
| Gesundheit |
| US14070B3096 / A2PLU4 |
| 4LN2 (Frankfurt) / CAPR (NASDAQ) |
| FRA:4LN2, ETR:4LN2, 4LN2:GR, NASDAQ:CAPR |
| - |
| https://capricor.com/ |
|
Capricor Therapeutics Inc. is a biotechnology comp..
>Volltext.. |
| 225.94 Mio. EUR |
| 157.13 Mio. EUR |
| 9.67 Mio. EUR |
| -73.76 Mio. EUR |
| -71.21 Mio. EUR |
| -1.56 EUR |
| 15.56 Mio. EUR |
| 16.95 Mio. EUR |
| -53.02 Mio. EUR |
| 3.5 |
| -54.53% |
| -128.05% |
| - |
| - |
| - |
| - |
| CAPRICOR THERAPEUTICS, CAPRICOR THERAPEUTIC |
| 24.11.25 |